Education
About Us
Working with TipRanks
Follow Us
Valiant Laboratories Ltd. (IN:VALIANTLAB)
:VALIANTLAB
Total Valuation
Valiant Laboratories Ltd. has a market cap or net worth of ₹4.51B. The enterprise value is ―.
Market Cap₹4.51B
Enterprise Value―
Share Statistics
Valiant Laboratories Ltd. has 54,312,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding54,312,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Valiant Laboratories Ltd.’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 7.24%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)7.24%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee18.03M
Profits Per Employee-285.87K
Employee Count77
Asset Turnover0.35
Inventory Turnover29.23
Valuation Ratios
The current PE Ratio of Valiant Laboratories Ltd. is 3018.2. Valiant Laboratories Ltd.’s PEG ratio is 0.22.
PE Ratio3018.2
PS Ratio2.47
PB Ratio1.46
Price to Fair Value1.46
Price to FCF-3.04
Price to Operating Cash Flow296.42
PEG Ratio0.22
Income Statement
In the last 12 months, Valiant Laboratories Ltd. had revenue of 1.39B and earned -22.01M in profits. Earnings per share was -0.51.
Revenue1.39B
Gross Profit222.17M
Operating Income178.29M
Pretax Income-15.13M
Net Income-22.01M
EBITDA7.55M
Earnings Per Share (EPS)-0.51
Cash Flow
In the last 12 months, operating cash flow was 13.13M and capital expenditures -1.14B, giving a free cash flow of -1.13B billion.
Operating Cash Flow13.13M
Free Cash Flow-1.13B
Free Cash Flow per Share-20.72
Dividends & Yields
Valiant Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.78
52-Week Price Change-23.01%
50-Day Moving Average85.18
200-Day Moving Average91.28
Relative Strength Index (RSI)43.45
Average Volume (3m)3.75K
Important Dates
Valiant Laboratories Ltd. upcoming earnings date is Nov 10, 2025, Before Open (Confirmed).
Last Earnings DateAug 8, 2025
Next Earnings DateNov 10, 2025
Ex-Dividend Date―
Financial Position
Valiant Laboratories Ltd. as a current ratio of 3.23, with Debt / Equity ratio of 51.93%
Current Ratio3.23
Quick Ratio3.16
Debt to Market Cap0.35
Net Debt to EBITDA154.58
Interest Coverage Ratio101.71
Taxes
In the past 12 months, Valiant Laboratories Ltd. has paid 6.89M in taxes.
Income Tax6.89M
Effective Tax Rate-0.46
Enterprise Valuation
Valiant Laboratories Ltd. EV to EBITDA ratio is 608.01, with an EV/FCF ratio of -4.08.
EV to Sales3.31
EV to EBITDA608.01
EV to Free Cash Flow-4.08
EV to Operating Cash Flow349.73
Balance Sheet
Valiant Laboratories Ltd. has ₹759.91M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹759.91M billion.
Cash & Marketable Securities₹759.91M
Total Debt₹0.00
Net Cash₹759.91M
Net Cash Per Share₹13.99
Tangible Book Value Per Share₹54.26
Margins
Gross margin is 13.68%, with operating margin of 12.84%, and net profit margin of -1.59%.
Gross Margin13.68%
Operating Margin12.84%
Pretax Margin-1.09%
Net Profit Margin-1.59%
EBITDA Margin0.54%
EBIT Margin-0.96%
Analyst Forecast
The average price target for Valiant Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast7.88%
EPS Growth Forecast―